Medical research

New therapy targets cause of adult-onset muscular dystrophy

People diagnosed with myotonic dystrophy type 1 have difficulty unclenching muscles due to a genetic defect that generates toxic material within their cells. There is currently no treatment. In a new report published in the ...

Parkinson's & Movement disorders

Parkinson's in a dish: Researchers reproduce brain oscillations

Abnormal oscillations in neurons that control movement, which likely cause the tremors that characterize Parkinson's disease, have long been reported in patients with the disease. Now, University at Buffalo researchers working ...

Oncology & Cancer

Knocking out deadly brain cancer with a dual therapy

Glioblastoma is an often fatal form of brain cancer, with only 5% of patients surviving beyond five years. The cancer is difficult to treat and almost always becomes resistant to treatment. As a result, recurrence of glioblastoma ...

Medications

Choosing over the counter drugs for COVID 19? It's complicated

COVID-19 illness may include symptoms such as a sore throat, fever, cough, and fatigue. In January, the United States Centers for Disease Control and Prevention (CDC) issued its most recent guidelines for the use of over-the-counter ...

Medical research

This gross mixture has big benefits for the study of bacteria

Animal models are a necessary research tool for understanding how diseases develop and how therapies work in biological systems and can be credited for breakthroughs ranging from effective antibiotics to the COVID-19 vaccines.

Diseases, Conditions, Syndromes

What happens if we run out of antibiotics?

Widespread use of antibiotics in humans and animals has created growing resistance to treatments. What will happen if nothing is done? We asked expert Piotr Garstecki.

page 3 from 8